News|Articles|January 2, 2024
Custom Traditional and Multi-Omics Media Development Enhances Antibody Production in CHO Cells (Jan 2024)
Author(s)Thermo Fisher Scientific
This case study summarizes the outcomes of several media optimization projects and how the results helped manufacturers to achieve their desired scale-up goals, including enhancing productivity, maintaining product quality, and potentially improving return on investment (ROI).
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
How ten23 health is Advancing Patient-Centric Drug Delivery
2
FDA, Duke University Planning Epinephrine Access Workshop for December
3
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
4
Drug Solutions Podcast: Innovations in Orphan Drugs for Rare Diseases
5
